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Objectives. To determine the post-procedure acceptability of self-collecting a vaginal swab for HPV testing
among a highly impoverished and geographically isolated population ofmedically underserved Blackwomen re-
siding in the Mississippi Delta. Further, to test correlates of reporting that self-collection is preferred over Pap
testing. Finally, to determine the prevalence of any of 13 high-risk HPV types among this population and the cor-
relates of testing positive.
Methods. Eighty-eight womenwere recruited from two churches located in different towns of theMississippi
Delta. After completing a survey, women were provided instructions for self-collecting a cervico-vaginal swab
and completing a post-collection survey. Specimens were tested for 13 oncogenic HPV types. Due to the explor-
atory nature of the study, significance was defined by a 0.15 alpha-level.
Results. Comfort levels with self-collection were high: 78.4% indicated a preference for self-collecting a spec-
imen compared to Pap testing. Overall, 24 women (28.7%) tested positive for one or more of the 13 HPV types.
Significant associations with testing positive were found for women having sex with females (P = 0.09), those
never having an abnormal Pap (P = 0.06), younger women (P = 0.10), those with greater fatalism scores
(P = 0.006), and those having less trust in doctors (P = 0.001).
Conclusions. Black ruralwomen from the deep-south are generally comfortable self-collecting cervico-vaginal
swabs for HPV testing. Given that nearly 30% tested positive for oncogenic HPV, and that fatalism aswell a lack of
trust in doctors predicted prevalence, a reasonable screening alternative to Pap testingmay be community-based
testing for HPV using self-collected vaginal swabs.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Cervical cancer mortality is largely preventable if women and pro-
viders follow Pap-testing guidelines (Centers for Disease Control and
Prevention andDepartment of Health andHuman Services). The recent-
ly approved the Cobas® Human Papillomavirus (HPV) Test (to detect
HPV types 16 and 18 and 12 other high-risk types) represents an addi-
tional screening method (Simon and American Cancer Society, 2014).
These tests can be performed on vaginal swabs and evidence suggests
that self-collection is easy to perform, provides privacy, and is less
embarrassing and more comfortable than physician-collected samples
(Igidbashian et al., 2011; Schmeink et al., 2011; Barbee et al., 2010;
Arriba et al., 2010; Huynh et al., 2010; Anhang et al., 2005; Dzuba
et al., 2002; Vanderpool et al., 2014).
The ability for women to self-collect vaginal swabs in a community
setting raises the question of whether cervical cancer screening
programs could transcend clinic boundaries. This may be useful inmed-
ically underserved areas, including rural counties isolated from services.
However, taboos on genital self-touching and collecting vaginal swabs
in public places may preclude this type of screening. This study sought
to determine the post-procedure acceptability of self-collecting a vagi-
nal swab for HPV testing among a highly impoverished and geographi-
cally isolated population of medically underserved Black women
residing in the Mississippi Delta. The intent was to test this non-
clinical method of screening among womenwho had not been recently
screened. Further, the study tested possible correlates of reporting that
self-collection is preferred over Pap testing. Also the study determined
the prevalence of high-risk HPV types and the correlates of testing
positive.
2. Methods
2.1. Study sample
Two churches located in different towns of the Mississippi Delta
served as recruitment sites. Two female research assistants obtained
Preventive Medicine Reports 7 (2017) 227–231
⁎ Corresponding author at: College of Public Health, 111 Washington Ave., Lexington,
KY 40506-0003, USA.
E-mail address: crosbyr3@gmail.com (R.A. Crosby).
http://dx.doi.org/10.1016/j.pmedr.2016.12.014
2211-3355/© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
Preventive Medicine Reports
j ourna l homepage: ht tp : / /ees.e lsev ie r .com/pmedr
permission and support from church ministers to recruit women after
Sunday services. As opposed to the research assistants approaching
women, women were told to find and talk with the research assistant
after services to learn about the study. Because print information had
been circulated relative to the study inclusion criteria, all women who
presented themselves to the research assistant were eligible. In the
course of five Sunday afternoon sessions (both churches combined)
88womenmeeting the eligibly requirements volunteered andwere en-
rolled. We limited the recruitment to five Sundays based on a need not
to overstay our welcome at these churches.
Eligibility criteria were: 1) being 30–65 years old, 2) not having a
Pap test in the past three years, 3) not currently pregnant, 4) never test-
ing HPV-positive, and 5) sexual activity in the past 12months. This final
criterion was included based on evidence that the median time to HPV
clearance in women is approximately 10 months (Winer et al., 2010).
Also, regarding the criterion of never testing HPV-positive, we were
content with reliance on women's self-report of this for two reasons:
1) HPV testing is a rare occurrence in the MS Delta and 2) asking per-
mission to access women's medical records for this information would
have led to a strong possibility of sample bias. Collectively, these criteria
provided a sample of women at-risk of HPV infections that may have
persisted to the point of undiagnosed cervical dysplasia or invasive can-
cer. The second criterion provided a sample of women who otherwise
would be considered non-compliant with public health screening
guidelines for cervical cancer. The third and fourth criteria were includ-
ed to help ensure a relatively naïve sample regarding current medical
care and past HPV. Recruitment occurred from March through June of
2015.
2.2. Procedures
All study procedures were approved by the Office of Research Integ-
rity at the sponsoring university. Womenwere informed that the study
involves four sequential tasks: 1) providing written informed consent,
2) answering questions in a short survey, 3) self-collecting a vaginal
specimen, and 4) completing a brief post-collection survey. Thus,
women began by completing a paper-and-pencil survey instrument
prior to receiving instructions for specimen collection. Survey questions
collected demographic and health information, as well as beliefs about
sexual health and HPV. Next, research assistant read aloud a specimen
collection instruction sheet, before providing a hard copy. Women
took the instructions into church restrooms. The instructions included
an illustration showing the insertion of the swab into the vagina and
the rotating motion of the swab to collect an adequate specimen. After
self-collecting, women then swirled the collection brush 40 times in a
specimen vial containing Preservecyt®, a fixing solution. They then
sealed the specimen vial, placed it in a pre-labeled bag, and returned
the sealed bag. Last, women completed a post-survey regarding their
self-collection experience. Women received $20 to compensate their
time. Samples were stored in a temperature-controlled environment
(30 °F or−1 °C) until they were shipped on dry ice to the participating
university laboratory.
2.3. Pre-collection measures
These measures included basic demographic variables and various
measures such as women's history of Pap testing, ever having HPV or
other sexually transmissible infections, whether friends or familymem-
bers were diagnosed with cervical cancer, and the number of male sex
partners (past 12 months). Two scale measures were included. A 6-
item scale assessed fatalism relative to cervical cancer (obtained
Cronbach's alpha=0.80). A sample item from that scale is, “Getting cer-
vical cancer is beyond my control.”
Also, a 5-item scale assessed trust in doctors (obtained Cronbach's
alpha = 0.82). A sample item from that scale is, “I trust doctors' judg-
ment about my medical care.”
2.4. Post-collection acceptability measures
After women self-collected the vaginal swabs, they were asked five
questions via paper-and-pencil survey (response options were “yes”
and “no” unless otherwise specified): 1) Did you feel that you under-
stood the directions for collecting the specimen?; 2) On a 5-point
scale with 5 being “comfortable” to 4 being “ somewhat comfortable,”
to 3 being “slightly comfortable” to 2 being “neither comfortable nor un-
comfortable,” to 1 being “uncomfortable”; 3) Did you experience any
pain during the collection process?; 4) Did you experience any bleeding
during the collection process, and 5) Would you be more likely to do
this test on a regular basis compared to having a regularly scheduled
Pap test?
2.5. Laboratory analysis
HPV was detected by Polymerase Chain Reaction analysis. Cellular
DNA was extracted from the swabs using a Qiagen DNA extraction kit.
The DNA was extracted from BSC cells as an extraction control with
every 20 samples (Chaturvedi et al., 2005). HPV DNA was amplified
and genotyped using the Roche reverse line blot system (Chaturvedi
et al., 2005; Gravitt et al., 1998). This assay used the extended-
spectrum and biotin-labeled L1 consensus (PGMY09/11, amplicon
450 bp) and biotin-labeled β-globin primers (PC04, GH20, amplicon
250 bp). Samples demonstrating the 450 bp L1 amplicon were geno-
typed using the 37 types contained on the reverse line blot: the 13
high-risk HPV types were16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59,
and 68. Any bands more intense than the low β-globin band intensity
were scored as positive.
2.6. Data analysis
To identify correlates of indicating that self-collection is preferred
over Pap testing bivariate tests of association (chi-squared tests or inde-
pendent groups t-tests) were conducted. To identify correlates of test-
ing positive for HPV bivariate tests of association were applied to nine
single-item measures and the two scale measures. Because of the ex-
ploratory nature of this study, a less conservative standard was used
to define significance (P b 0.15) and effect size estimates were calculat-
ed for dichotomous outcomes (using the risk ratio) and continuous out-
comes (using the percent relative difference).
3. Results
Average age of the sample was 46.5 years (standard deviation =
9.0 years). All women identified as non-Hispanic Black. A monthly
household monthly income of less than $2000 was reported by 40.9%,
with 28.4% reporting incomes between $2000 and $3000, and 30.7%
reporting incomes above $4000. Just over one-half of the sample
(55.7%) indicated not having children who lived with them, 22.7% re-
ported having one child living with them, and the remainder had two
or more living with them. Less than one-half (44.3%) were married at
study enrollment.
3.1. Acceptance of the self-collection process
Only onewoman of the 88 enrolled, reported she did not understand
the directions for self-collecting the specimen. When asked “how com-
fortable were you with collecting the specimen,” 35.2% selected the op-
tion of “comfortable,” 19.3% selected “somewhat comfortable,” 22.7%
selected “slightly comfortable,” 13.0% selected “neither comfortable
nor uncomfortable,” and 8.0% selected “uncomfortable.” Seventeen per-
cent reported experiencing somepain during the collection process, and
12.5% reported bleeding during the collection process. A majority
(78.4%) reported they would you be more likely to do this test on a reg-
ular basis compared to having Pap tests.
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3.2. Correlates of reporting that self-collection is preferred
Table 1 displays associations between 9dichotomously assessed var-
iables and whether women indicated that self-collection is preferable
over Pap testing. As shown, of the 9 variables tested only one
(i.e., having multiple male partners) was significant using the explor-
atory alpha of 0.15. Additionally, 6 variables assessed at the continuous
level were tested (Table 2). As shown, twomeasuresmet the explorato-
ry level of significance. First, women expressing a preference for self-
collection had a higher mean score on the post-collection measure of
comfort during the self-collection process. Second, the scale measure
of trust in medical doctors produced means differing significantly be-
tween women not expressing a preference for self-collection and
those expressing this preference.
Both Tables 1 and 2 additionally display the obtained effect sizes.
3.3. Prevalence and correlates of testing positive for HPV
Overall, 24 women (28.7%) tested positive for one or more of the 13
HPV types. Thirteen of these tested positive for one type, 5 tested posi-
tive for two types, 4 tested positive for three types, and 2 tested positive
for four types.
Table 3 displays associations between 8dichotomously assessed var-
iables and testing positive for HPV. As shown, 2 of the 8 associations
were significant at the exploratory level, i.e., sex with females in the
past 12 months (risk ratio = 2.40) and ever having an abnormal Pap
test result (risk ratio = 0.39).
Table 4 displays associations between 3 continuously assessed vari-
ables and testing positive for HPV. As shown, age was also significantly
associated with testing positive for HPV. Women testing HPV positive
were younger compared to those testing negative for HPV. Also, both
scale measures were significantly associated with testing positive for
HPV. The mean score on the measure of fatalism was 13.0 among
those testing positive compared with 9.05 among those testing nega-
tive. The range on this measure was 0 to 24, with higher scores
representing greater level of fatalism, thus the observed difference of
~4.0 represents a substantially greater level of fatalism in those testing
positive. The percent relative difference for this measure of fatalism
was large (43.64). The mean score on the measure of trust in doctors
Table 2
Continuous bivariate associations of reporting that self-collection (SC) is preferred over Pap testing (N = 88).
Correlate Women not preferring SC (19) Women preferring SC (69) t PRDa P
Mean age (years) 45.1 46.8 0.74 3.77 0.46
Level of agreementb
“Pap test is a hassle”b 5.79 5.42 0.49 6.39 0.62
“Past test too expensive” 6.31 6.18 0.66 2.06 0.51
Level of comfort in SCc 2.21 2.72 1.51 23.07 0.14⁎
Level of fatalismd 9.89 10.27 0.24 3.84 0.81
Level of trust in doctorse 17.36 15.36 2.05 11.52 0.046⁎
a Percent relative difference.
b Assessed on visual analogue scale ranging from 1 (“agree”) to 9 (“disagree”).
c Assessed on scale ranging from 0 (“uncomfortable”) to 4 (“comfortable”).
d Assessed with a 6-item scale with scores ranging from 0 (no fatalism) to 24 (high fatalism).
e Assessed with a 5-item scale with scores ranging from 1 (no trust) to 25 (complete trust).
⁎ Significant based on the exploratory level of 0.15.
Table 1
Dichotomous bivariate associations of reporting that self-collection is preferred over Pap
testing (N = 88).
Variable
n(%) preferring
self-collection RRa P
Some pain during self-collectionb
No (n = 72) 59 (81.9)
Yes (n = 15) 10 (66.7) 0.81 0.18
Some blood during self-collectionb
No (n = 76) 58 (76.3)
Yes (n = 11) 10 (90.9) 1.19 0.27
Friend/family members diagnosed w/ cervical cancerb
No (n = 69) 52 (75.4)
Yes (n = 18) 16 (88.9) 1.18 0.22
Ever had an abnormal Pap test result
No (n = 65) 51 (78.5)
Yes (n = 23) 18 (78.3) 0.99 0.98
Ever had a Pap testb
No (n = 23) 18 (78.3)
Yes (n = 64) 50 (78.1) 0.99 0.87
Ever diagnosed with a sexually transmitted infectionc
No (n = 61) 48 (78.7)
Yes (n = 25) 19 (76.0) 0.96 0.78
Likelihood of having next scheduled Pap testb
Not likely (n = 20) 17 (85.0)
Likely (n = 67) 50 (76.1) 0.89 0.40
More than one male sex partner, past 12 months
No (n = 75) 61 (81.3)
Yes (n = 13) 8 (61.5) 0.76 0.11⁎
“I would feel dirty if a doctor examined me for HPV”
Disagree (n = 70) 74 (77.1)
Agree (n = 18) 15 (83.3) 1.08 0.57
a Risk ratio.
b Data from one woman was missing from this variable.
c Data from two women were missing from this variable.
⁎ Significant based on the exploratory level of 0.15.
Table 3
Dichotomous bivariate associations of testing HPV positive (N = 88).
Variable % testing positive RR1 P
Married
No (n = 46) 28.3
Yes (n = 39) 28.2 0.99 0.82
Income b $2000 per month
No (n = 50) 28.0
Yes (n = 36) 27.8 0.99 0.98
More than one male sex partner, past 12 months
No (n = 74) 27.0
Yes (n = 12) 33.3 1.23 0.65
Sex with females, past 12 months
No (n = 80) 25.0
Yes (n = 5) 60.0 2.40 0.09⁎
Ever had an abnormal Pap test result
No (n = 63) 33.0
Yes (n = 23) 13.0 0.39 0.06⁎
Ever diagnosed with a sexually transmitted infection
No (n = 59) 23.7
Yes (n = 25) 36.0 1.52 0.25
“I would feel dirty if a doctor examined me for HPV”
Disagree (n = 69) 24.6
Agree (n = 17) 41.2 1.67 0.17
Penile-vaginal sex, past 12 months
No (23) 17.4
Yes (62) 31.7 1.82 0.19
⁎ Significant based on the exploratory level of 0.15.
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(range 1 to 25, with higher scores representing greater levels of trust)
was 12.75 among those testing positive compared with 17.11 among
those testing negative. The percent relative difference for this variable
was also large (25.73).
4. Discussion
Because the consent process included the point that women would
be asked to self-collect a cervico-vaginal swab, the study was not de-
signed to describe or quantify the refusal to self-collect. Instead, the
study was designed to determine women's acceptance of the self-
collection procedure after they had performed it. That more than
three-quarters of the sample indicated, in the post-collection survey,
they preferred this method of cervical cancer screening to Pap testing
is an important finding and one that is consistent with similar research
with populations of urban women (Igidbashian et al., 2011; Schmeink
et al., 2011; Barbee et al., 2010; Arriba et al., 2010; Huynh et al., 2010;
Anhang et al., 2005; Dzuba et al., 2002; Vanderpool et al., 2014). Finding
that the 17% reporting some pain during self-collection were less likely
to express this preference was not surprising, but it does suggest that
practice-based programs using self-collection should provide instruc-
tions to women such that any pain in self-collection is minimal. As
found in this study, comfort in self-collecting is a strong correlate of pre-
ferring this method of screening (the percent relative difference for this
association was 23.07). Further, it is noteworthy that the percent rela-
tive difference in mean scores for the scale measure of trust in doctors
was 11.5, indicating that women lacking this trust are potentially
more likely to prefer self-collection over Pap testing. That women
with recent multiple male sex partners were less likely to express this
preference may be a consequence of their greater presumed risk and
thus their sense of a need for added protectionmay compel them to tra-
ditional care. Of note, neither age nor the measure of fatalismwas asso-
ciated with preferring this method of screening.
The observed prevalence of oncogenic HPV approached 30%. Al-
though the majority of these infections are unlikely to ever progress to
cervical dysplasia and cervical cancer, the relatively high rate suggests
the utility of screening women, in this population, for HPV who have
not had a Pap test within the past 3 years (a study inclusion criterion).
The ubiquitous nature of HPV makes it difficult to identify markers of
likely infection; however, we did identify two markers of interest.
First, women never having an abnormal Pap result were more likely to
test positive. Thismay be due to persistent and untreated HPV infection,
or due to greater vigilance in self-protection on the part of women hav-
ing an abnormal Pap. Second, HPV infection was more likely among
those also having female sex partners. This may be an artifact of the
low number of women reporting sex with other women (n = 5) or it
may be verymuch a consequence of labia to labia/vaginal HPV transmis-
sion, digital to labia/vaginal transmission, or oral to labia/vaginal
transmission.
4.1. Limitations
Findings are limited by the use of a convenience sample and by the
validity of the self-reported data. As an exploratory study, findings are
also limited by the very small sample size and the corresponding lack
of statistical power. Further, from an external validity standpoint, it
should be noted that the compensation provided to women for com-
pleting the assessment may have motivated them to agree to self-
collection thus whether similar results would occur in the absence of
this compensation is not known. As an addition limitation, it is notewor-
thy that the inclusion criterion of not having a Pap test in the past
3 years may have nonetheless included women who were compliant
with screening guidelines (given the extended interval of up to
5 years for women screened by co-testing). Also, it must be noted that
women were selected for this sample based on lack of Pap testing in
the past three years, thereby precluding generalization to all rural
Black women residing in this part of the Mississippi Delta. Finally,
based on the point that these women had not had a Pap test in at least
three years, the finding regarding women's preference of self-collected
swabs over Pap testing is limited by this large gap in time that elapsed.
5. Conclusions
Findings suggest the possibility that optimizing community-based
screening for cervical cancer among rural Black women in the Deep
South may be achieved, in part, through church-based programs offer-
ing HPV testing via the option of self-collecting a vaginal swab. That
women self-collected in their church is an important finding in this re-
gard as it suggests that such programs could be faith-based. Black rural
women from the Deep South are generally comfortable self-collecting
cervico-vaginal swabs for HPV testing. Given that nearly 30% tested pos-
itive for oncogenic HPV, the utility of this screeningmethod appears fea-
sible and practical. Future studies should test strategies that navigate
rural, underserved Blackwomenwho do test positive for HPV to colpos-
copy or Pap testing.
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